昭衍新药
(603127)
| 流通市值：187.51亿 | | | 总市值：222.89亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2025-11-17 | -291.50万 | -0.66% | -6858.97万 | -15.50% | -960.53万 | -2.17% | 8111.00万 | 18.33% |
| 2025-11-14 | -1652.66万 | -3.78% | -750.17万 | -1.72% | 290.82万 | 0.67% | 2112.00万 | 4.83% |
| 2025-11-13 | 2395.84万 | 5.06% | -995.19万 | -2.10% | -658.80万 | -1.39% | -741.86万 | -1.57% |
| 2025-11-12 | 885.21万 | 1.78% | 1212.45万 | 2.44% | -1124.37万 | -2.26% | -973.29万 | -1.96% |
| 2025-11-11 | -1676.97万 | -4.91% | -3356.55万 | -9.83% | 455.42万 | 1.33% | 4578.10万 | 13.41% |
| 2025-11-10 | 1092.23万 | 2.25% | 1277.17万 | 2.63% | -416.53万 | -0.86% | -1952.88万 | -4.02% |
| 2025-11-07 | -4548.37万 | -9.44% | -5750.57万 | -11.94% | -847.76万 | -1.76% | 11146.70万 | 23.14% |
| 2025-11-06 | -2856.98万 | -6.79% | -1880.42万 | -4.47% | 699.66万 | 1.66% | 4037.73万 | 9.60% |
| 2025-11-05 | -3462.78万 | -6.13% | -3617.66万 | -6.41% | -1622.07万 | -2.87% | 8702.52万 | 15.41% |
| 2025-11-04 | -4485.46万 | -6.21% | -6672.37万 | -9.24% | -1780.95万 | -2.47% | 12938.78万 | 17.91% |